Forte Biosciences Inc.

NAS: FBRX

GO
/marketstate/country/us

Market closed

/zigman2/quotes/210207744/composite

$

1.00

Change

-0.01 -0.99%

Volume

Volume 32,154

Feb 8, 2023, 3:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/210207744/composite

Previous close

$ 1.01

$ 1.00

Change

-0.01 -0.99%

Day low

Day high

$1.00

$1.02

Open
Open: 1.01

52 week low

52 week high

$0.90

$1.64

Open

Market cap

$21.21M

Average volume

43,358

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.79

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/fbrx

MarketWatch News on FBRX

  1. Forte Biosciences downgraded to neutral from buy at B. Riley

    6:53 a.m. Sept. 3, 2021

    - Tomi Kilgore

  2. Forte Biosciences stock price target cut to $3 from $73 at B. Riley

    6:53 a.m. Sept. 3, 2021

    - Tomi Kilgore

  3. Forte Biosciences started at buy with $73 stock price target at B. Riley

    6:48 a.m. May 14, 2021

    - Tomi Kilgore

  4. Forte Biosciences initiated at buy with $70 price target at Truist Securities

    7:29 a.m. Aug. 25, 2020

    - Tonya Garcia

  5. Tocagen stock price target cut to $1 from $22 at B. Riley FBR

    6:19 a.m. Sept. 13, 2019

    - Tomi Kilgore

  6. Tocagen downgraded to neutral from buy at B. Riley FBR

    6:19 a.m. Sept. 13, 2019

    - Tomi Kilgore

  7. Tocagen downgraded to in line from outperform at Evercore ISI

    10:05 a.m. Sept. 12, 2019

    - Tomi Kilgore

  8. Tocagen price target lowered to $5 from $11 at SVB Leerink

    6:53 a.m. May 10, 2019

    - Tonya Garcia

  9. Tocagen started at market perform with $11 stock price target at SVB Leerink

    6:53 a.m. April 15, 2019

    - Tomi Kilgore

  10. Tocagen started at outperform with $28 stock price target at Evercore ISI

    3:20 p.m. May 8, 2017

    - Tomi Kilgore

  11. Tocagen started at buy with $24 stock price target at Stifel Nicolaus

    6:15 a.m. May 8, 2017

    - Tomi Kilgore

  12. Four Small Biotechs See Bullish April Stock Buys

    4:51 a.m. May 3, 2017

    - Barron's Online

  13. Gene therapy company Tocagen prices offering at low end of range

    7:43 a.m. April 13, 2017

    - Caitlin Huston

  14. Tocagen prices IPO at $10 a share

    7:31 a.m. April 13, 2017

    - Ciara Linnane

Analyst Ratings

/news/nonmarketwatch/company/us/fbrx

Other News on FBRX

  1. Forte Biosciences GAAP EPS of -$0.18 misses by $0.03

    6:13 a.m. Nov. 15, 2022

    - Seeking Alpha

  2. RUN, ARRY and SHLS are among pre market gainers

    8:04 a.m. Aug. 5, 2022

    - Seeking Alpha

  3. 10-Q: FORTE BIOSCIENCES, INC.

    7:36 a.m. May 16, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. Warning: FBRX is at high risk of performing badly

    5:18 a.m. Nov. 2, 2021

    - Seeking Alpha

  5. Warning: FBRX is at high risk of performing badly

    3:55 a.m. Nov. 2, 2021

    - Seeking Alpha

  6. BiomX: Undervalued With Multiple Upcoming Catalysts

    5:42 p.m. Oct. 6, 2021

    - Seeking Alpha

  7. Wall Street Breakfast: What Moved Markets

    7:25 a.m. Sept. 4, 2021

    - Seeking Alpha

  8. JOBY, FTFT and CLIR among mid-day movers

    11:34 a.m. Sept. 3, 2021

    - Seeking Alpha

  9. Why Forte Biosciences Stock Is Imploding Today

    10:21 a.m. Sept. 3, 2021

    - Motley Fool

  10. Forte Bio draws downgrades after setback in dermatitis trial

    2:11 a.m. Sept. 3, 2021

    - Seeking Alpha

  11. Loading more headlines...
/news/pressrelease/company/us/fbrx

Press Releases on FBRX

  1. Mr. David Gryska Appointed to Forte Biosciences Board of Directors

    4:05 p.m. Jan. 12, 2023

    - BusinessWire - BZX

  2. Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors

    4:01 p.m. Nov. 14, 2022

    - BusinessWire - BZX

  3. Best Penny Stocks to Buy Today? 3 to Watch on May 3rd

    8:34 a.m. May 3, 2022

    - Penny Stocks

Rates »

Link to MarketWatch's Slice.